Skip to main content

Legal & General Group Plc

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 764068 London, X0

Position in APLS

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$0
+$0 QoQ
Shares Held
228,255
+167.0% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 228,255
2025-12-31 85,489
2025-09-30 92,392
2025-06-30 96,050
2025-03-31 79,070
2024-12-31 86,771
2024-09-30 87,963
2024-06-30 91,671
2024-03-31 85,844
2023-12-31 83,471
2023-09-30 81,778
2023-06-30 84,151
2023-03-31 86,668
2022-12-31 80,394
2022-09-30 80,642
2022-06-30 81,974
2022-03-31 70,357
2021-12-31 69,167
2021-09-30 57,899
2021-06-30 45,707
2021-03-31 45,097
2020-12-31 45,167
2020-09-30 40,130
2020-06-30 20,743
2020-03-31 11,607